Treatment of Bleeding Diathesis Associated with a Heparin-Like Anticoagulant in Plasma Cell Neoplasia Using Protamine

Case Reports in Hematology
Christopher A Willner, Mohammed M Chisti

Abstract

The development of a heparin-like anticoagulant (HLAC) in plasma cell neoplasia has previously been described in clinical literature. Testing of this HLAC, primarily in vitro, has demonstrated that neutralization may be achieved with protamine sulfate, owing to antithrombin III cofactor activity. We report a case in which intravenous protamine sulfate was administered to a patient with IgG-kappa monotypic multiple myeloma, which resulted in resolution of bleeding and coagulopathy, confirmed via objective laboratory data. Our case is intended to demonstrate that intravenous protamine sulfate should be considered in acute bleeding with plasma cell neoplasia. We review the literature to observe past experiences about this phenomenon. We postulate that chemotherapy, targeted therapies, and immunotherapies may also disrupt production of a HLAC. With further investigation, this strategy could be applicable in other hematological malignancies with bleeding diathesis, chiefly if the pathophysiology of the HLAC is precisely defined.

References

Feb 1, 1990·The American Journal of Medicine·A TefferiE J Bowie
Jun 28, 1984·The New England Journal of Medicine·R N PalmerH R Gralnick
Mar 1, 1980·The Journal of Clinical Investigation·M S KhooryK G Mann
Oct 18, 1984·The New England Journal of Medicine
Jul 10, 2001·American Journal of Hematology·P LlamasJ F Tomás
Oct 24, 2001·Journal of Hematotherapy & Stem Cell Research·M W SaifB Greenberg
Apr 7, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Lamia TorjemaneAbdeladhim Ben Abdelhadhim
Feb 13, 2009·British Journal of Haematology·Charles Eby

❮ Previous
Next ❯

Citations

Oct 21, 2020·Leukemia & Lymphoma·Ahmed Shekib ZaheirNesar Ahmed Zaheir

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.